Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Pancreatic Cancer
  •  Radiological Techniques and Scans
  •  Targeted Therapy
  •  Gynecological Cancers
  •  Palliative Care
  •  Melanoma/Skin Cancer
  •  Immunology
  •  Chemotherapy and Radiotherapy

Abstract

Citation: Clin Oncol. 2016;1(1):1083.DOI: 10.25107/2474-1663.1083

Usefulness of Pet/Ct in Preoperative Staging of Nsclc Patients

Santhosh S, Sunil HV, Kashyap KR, Bhattacharya A and Mittal BR


Department of Nuclear Medicine and PET, PGIMER, India

*Correspondance to: Santhosh S 

 PDF  Full Text Research Article | Open Access

Abstract:

Aim: To evaluate the usefulness of integrated positron emission tomography and computed tomography (PET/CT) in preoperative staging of patients with non-small cell lung carcinoma (NSCLC).
Methods: Twenty nine histopathologically proven patients of NSCLC having CT based staging were subjected to PET/CT imaging. PET/CT was done 60 min after the intravenous injection of 18F-FDG. Whole body imaging (base of skull to mid thigh region) was performed in all patients.
Results: Based on staging, disease was considered as nonresectable if staging ≥IIIB. Of the 29 patients studied, CT showed resectable disease in 21 & nonresectable in 8 patients; PET/ CT showed resectable disease in 15 & nonresectable in 14 patients. By PET/CT findings, 7 patients were changed from resectable to non-resectable group and one patient from non-resectable to resectable group. Hence, in 27.5% (8/29) of patients, change in management was achieved. PET/CT upstaged 12 patients (41.3%), downstaged3 patients (10.3%) & confirmed staging in 14 patients (48.3%) compared to CT. Upstaging was done by the finding of nodal status in 6 and metastases in 6 patients. PET/CT downtaged 3 patients. (One suspected liver metastasis was found to be benign; mediastinal nodal involvement was ruled out in two patients). PET/CT was found to be more useful in the evaluation of nodal status and metastasis involvement which are the major determinants of respectability in patients with NSCLC.
Conclusion: PET/CT showed excellent utility in the initial staging of patients with NSCLC. PET/CT changed the management, by deferring futile surgery, in approximately 24% of the patients. PET/ CT should be considered mandatory in all patients considered to have resectable NSCLC.

Keywords:

Cite the Article:

Santhosh S, Sunil HV, Kashyap KR, Bhattacharya A, Mittal BR. Usefulness of Pet/Ct in Preoperative Staging of Nsclc Patients. Clin Oncol. 2016; 1: 1083.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Erlotinib Treatment Beyond Progression in EGFR Mutant Patients Who Have Responded to EGFR TKIs in Stage IIIB/IV NSCLC: An Open Label Randomized Trial
 Abstract  PDF  Full Text
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Microcalcifications: A Study Based on the 5th Edition of BI-RADS
 Abstract  PDF  Full Text
View More...